Quality Solutions That Reduce Compliance Risks in Clinical Trials

Choose from specialized solutions that help you increase quality and efficiency.

Person on computer running quality assurance check

Why QA Teams Love TransPerfect

Our knowledge and experience in Quality Management is evidenced by our ability to create and curate strategic solutions to improve day-to-day operations / reducing administrative burdens. We have 30+ years of experience customizing these solutions. Here are some of your options:

QMS Powered by Trial Interactive

Our suite of eClinical solutions—part of TransPerfect’s Trial Interactive™ offering—improves visibility, reduces timelines, enhances quality, and mitigates risk. Explore our solutions for quality management, training management, audit management, vendor oversight, quality documents, and more.

Learn More

Training and Development

We offer training support across any platform, in 200+ languages, and any subject matter. Our team centralizes your global learning requirements and manages the administrative work, so you can roll out your content quickly and cost-effectively.

Learn More

Language/Translation Solutions

Ensure conceptual equivalence and cultural appropriateness in any language, minimizing time-to-market, mitigating risk, and ensuring compliance in global studies.

Learn More

Your Partner in Risk Mitigation

Ensuring quality from R&D through commercialization is complex due to ever-evolving regulations, international policy, and corporate change, among many other variables. QA teams need all the support they can get to embed quality in the organizational culture through efficiencies such as digital and automated work streams, real-time oversight, e-learning, and translated quality documentation for multilingual operations.

Improved Outcomes by the Numbers

85% of clinical trials experience delays. Mitigating compliance risks by streamlining QA operations is a key strategy for preventing costly delays caused by CAPAs and inspection findings.

1.2 M

Saved by CRAs using our CTMS for day-to-day operations

7.5 k

Studies managed in Trial Interactive

100 +

TMFs rescued mid-study

3 k

eTMF study migrations completed

50 %

Faster site activation

News and Thought Leadership

Industry insights from our experts. We have the experience and solutions you need to navigate life sciences complexity and bring breakthroughs from lab to launch.

AI Governance in Medical Information: What "Human-in-the-Loop" Actually Requires

Blog

These days, you can't have a conversation about AI in life sciences without someone invoking "human-in-the-loop." It's become so expected that leaving it out feels like a red flag—a signal that AI governance hasn't been fully considered. The problem isn't the phrase itself. It’s what organizations think it means. When most pharma teams say human-in-the-loop, what they actually have is a human somewhere in the process. That's not an AI governance strategy. And if that ...

AI Governance in Medical Information: What "Human-in-the-Loop" Actually Requires

White Paper

Libraries in Clinical Outcome Assessments: How Valuable Are They—and Are They the Panacea They’re Claimed to Be?

Speed, cost, and quality are competing priorities in eCOA localization. Discover why translation libraries alone aren't enough, and what combination of proactive licensing, automation, and integrated technology can transform your deployment timelines. ...

Blog

From Reactive to Strategic: How AI Is Transforming Medical Information Contact Centers

IntroductionFor decades, Medical Information (MI) has been an essential function within pharma, but largely a reactive one. This is especially true in medical information contact centers, which serve as the first line of support for HCPs and patients. When someone has a...

Blog

Is AI Ready to Transform COA Development?

AI is reshaping clinical development, but its greatest value may lie not in replacing human expertise, but rather in augmenting it. Across the drug development pipeline, AI is helping teams analyze vast datasets faster, identify promising compounds earlier, and uncover...

Blog

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs...

Webinar

AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale

Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build ...

Webinar

Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...